Kaiser Permanente - Orange County - Anaheim Medical Center — Anaheim, California

Kaiser Permanente - Orange County - Anaheim Medical Center is a clinical research site located in Anaheim, California, United States 92806.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente - Orange County - Anaheim Medical Center has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia.

Sponsors: Jazz Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Anaheim

Browse all research sites in California · View every site in Anaheim

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente - Orange County - Anaheim Medical Center?

Kaiser Permanente - Orange County - Anaheim Medical Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente - Orange County - Anaheim Medical Center conducted?

Kaiser Permanente - Orange County - Anaheim Medical Center has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia.

Is Kaiser Permanente - Orange County - Anaheim Medical Center accredited by Crixeo Clinical Trials?

Kaiser Permanente - Orange County - Anaheim Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente - Orange County - Anaheim Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.